Calidi Biotherapeutics, Inc. · AMEX:CLDI
Armistice Capital, LLC's stake in Calidi Biotherapeutics, Inc. fell to 4.99% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Armistice Capital, LLC's stake in Calidi Biotherapeutics, Inc. fell to 4.99%, 117,368 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 4.99%
- Shares
- 117,368
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 4.99% | 117,368 |
| Steven Boyd | 4.99% | 117,368 |
Source
Related
- Calidi Biotherapeutics, Inc.
- Armistice Capital, LLC
- Calidi Biotherapeutics, Inc. shareholders
- Schedule 13G · Armistice Capital, LLC · May 15, 2026
- Schedule 13D · Gavrilov Ognian Anguelov · Mar 31, 2026
- Schedule 13D · Gavrilov Ognian Anguelov · Mar 9, 2026
- Schedule 13G/A · Lincoln Alternative Strategies LLC · Feb 10, 2026
- Schedule 13G · Gavrilov Ognian Anguelov · Feb 4, 2026
- Schedule 13G · Lincoln Alternative Strategies LLC · Aug 27, 2025